Bibliography
- FDA U.S. Food and Drug Administration. Adverse Events Reporting System (AERS. Accessed February 15, 2011
- Bailey S, Singh A, Azadian R, Prospective data mining of six products in the US FDA adverse event reporting system: disposition of events identified and impact on product safety profiles. Drug Saf 2010;33:139-46
- Hansen RA, Gartlehner G, Powell GE, Serious adverse events with infliximab: analysis of spontaneously reported adverse events. Clin Gastroenterol Hepatol 2007;5:729-35
- FDA U.S. Food and Drug Administration. FDA Drug Safety Communication: New Boxed Warning on severe liver injury with propylthiouracil. Available from: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm209023.htm [Accessed 15 February 2011]
- Rivkees SA, Szarfman A. Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children. J Clin Endocrinol Metab 2010;9:3260-7
- Gardner G, Gardner A, Middleton S, The work of nurse practitioners. J Adv Nurs 2010;66:2160-9
- Maehara T, Nishida H, Watanabe T, Surgeons' hope: expanding the professional role of co-medical staff and introducing the nurse practitioner/physician assistant and team approach to the healthcare system. Nippon Geka Gakkai Zasshi 2010;111:209-15
- Classen DC, Resar R, Griffin F, “Global trigger tool” shows that adverse events in hospital may be ten times greater than previously measured. Health Aff (Millwood) 2011;30:581-9
- Fukuda H, Imanaka Y, Hirose M, Impact of system-level activities and reporting design on the number of incident reports for patient safety. Qual Saf Health Care 2010;19:122-7
- Woolsey CV. A Patient's Guide to the Physician Assistant. Available from: http://www.pg2pa.org/PA_NP.html [Accessed 19 November 2011]
- Bates DW, Cullen DJ. Laird, et al. Incidence of adverse drug events and potential drug events-Implications for prevention. JAMA 1995;274:29-34
- Kunac DL, Kennedy J, Austin N, Incidence, preventability and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study. Paediatr Drugs 2009;11:153-60
- Kilbridge PM, Noirot LA, Reichley RM, Computerized surveillance for adverse drug events in a pediatric hospital. JAMA 2009;16:607-12
- Cullen DJ, Bates DW, Small SD, The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv 1995;21:541-8
- McClure DL. Improving drug safety: active surveillance systems should be paramount. Pharm Med 2009;23:127-30
- Ginsburg L, Norton PG, Casebeer A, An educational intervention to enhance nurse leaders' perceptions of patient safety culture. Health Serv Res 2005;40:997-1020
- Gardiner P, Sarma DN, Dog TL, The state of dietary supplement adverse event reporting in the United States. Pharmacoepidemiol Drug Saf 2008;17:962-70
- Hooker RS, Berlin LE. Trends in the supply of physician assistants and nurse practitioners in the United States. Health Aff (Millwood) 2002;21:174-81
- McCann JL, Phillips RS, O'Neil EH, Physician assistant and nurse practitioner workforce trends. Am Fam Physician 2005;72:1176